GLMD Short Information Galmed Pharmaceuticals Ltd.

Twenty Trading Day Totals
Total Shorted Volume	122,410
Total Actual Volume	1,013,139

Averages
Average Short Volume	6,121
Average Short Percentage	33.93%

Is there a GLMD Short Squeeze or Breakout about to happen?

See the GLMD Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-09-27	0.32995	0.31	0.331999	0.31	26,053	6,887	48.1844
2022-09-26	0.33	0.33	0.3399	0.33	39,314	4,378	24.6620
2022-09-23	0.36	0.346	0.3601	0.33	56,663	2,943	14.7438
2022-09-22	0.38	0.3712	0.38	0.35	42,740	11,603	57.6604
2022-09-21	0.391895	0.38	0.3925	0.38	79,710	28,627	60.9072
2022-09-20	0.4158	0.3963	0.43	0.35	112,738	2,319	5.5313
2022-09-19	0.4355	0.4201	0.4898	0.42	25,213	513	7.3077
2022-09-16	0.47	0.4355	0.47	0.43	13,182	3,345	75.1179
2022-09-15	0.42	0.4601	0.4675	0.42	59,365	17,178	54.9063
2022-09-14	0.48	0.4401	0.48	0.434351	19,179	406	13.3773
2022-09-13	0.4229	0.4617	0.4675	0.4201	63,023	7,117	35.5317
2022-09-12	0.3748	0.4292	0.43	0.3748	171,524	2,738	5.8153
2022-09-09	0.4167	0.425	0.4523	0.41	79,615	1,492	5.8030
2022-09-08	0.434899	0.421	0.434899	0.411	19,587	2,428	47.3941
2022-09-07	0.4241	0.420101	0.4349	0.4133	51,347	3,730	10.6852
2022-09-06	0.430201	0.4132	0.4497	0.4131	25,101	113	1.4102
2022-09-01	0.43	0.4451	0.47	0.43	38,591	7,296	53.1662
2022-08-31	0.46	0.4641	0.4641	0.4501	36,425	2,564	19.5352
2022-08-30	0.46	0.46	0.4773	0.4555	22,694	8,331	86.9352
2022-08-29	0.48	0.46	0.48	0.4556	31,075	8,402	49.9228

Stock Information

Galmed Pharmaceuticals Ltd. Company Name:

GLMD Stock Symbol:

NASDAQ Market:

Get GLMD Alerts

News, Short Squeeze, Breakout and More Instantly...

GLMD - Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results PR Newswire TEL AVIV, Israel , Aug. 4, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage bio...
GLMD - Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model PR Newswire Statistically significant clinical and histology improvements were also demonstrated in a model of inflammatory bowel disease (IBD) Data reinforcing the expansio...
GLMD - Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire TEL AVIV, Israel , June 17, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical ...